CN102258702A - Medicine for treating hypertension - Google Patents
Medicine for treating hypertension Download PDFInfo
- Publication number
- CN102258702A CN102258702A CN2011102638634A CN201110263863A CN102258702A CN 102258702 A CN102258702 A CN 102258702A CN 2011102638634 A CN2011102638634 A CN 2011102638634A CN 201110263863 A CN201110263863 A CN 201110263863A CN 102258702 A CN102258702 A CN 102258702A
- Authority
- CN
- China
- Prior art keywords
- medicine
- treating hypertension
- treatment
- powder
- hypertensive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a medicine for treating hypertension. The preparation method of the medicine comprises the following steps: preparing leech, centipede, lumbricus, astragalus root and gastrodia tuber which are washed with clear water, and evenly mixing; crushing the mixed materials into powder of 100-120 meshes; and packing the powder into capsules, sterilizing and disinfecting to obtain capsules. The medicine provided by the invention has efficacies of calming liver to stop endogenous wind and relieving peripheral arteriolar spasm; and the medicine for treating hypertension has the advantages of quick effect acting and no side effect.
Description
Technical field
The present invention relates to the hypertensive medicine of a kind of treatment, particularly relating to a kind of is the hypertensive medicine of treatment of crude drug preparation with Chinese medicine.
Background technology
Hypertension is a kind of chronic disease that serves as main performance with the lasting rising of arteriotony, often causes the pathological changes of vitals such as the heart, brain, kidney and corresponding consequence occurs.Secular hypertension can cause cardiovascular disease such as myocardial infarction, coronary heart disease etc., can also cause renal arteriosclerosis, thereby causes renal insufficiency, uremia etc.
Owing to hypertension incidence reason complexity, mainly be to realize to hypertensive treatment by controlling blood pressure, adopt Western medicine control, but the Western medicine side effect is big, is not suitable for permanent use more.
Summary of the invention
The purpose of this invention is to provide the hypertensive medicine of a kind of treatment, this medicine is made up of Chinese medicine, has suppressing the hyperactive liver to relieve the wind syndrome, alleviate the effect of periphery arteriolospasm, thereby the QI and blood of containing was descended, reached the purpose of blood pressure lowering, be used for the purpose that hypertensive treatment can be played good effect, have no side effect.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Hirudo 4～6 Scolopendras 8～12 Pheretimas 16～24
The Radix Astragali 8～12 Rhizoma Gastrodiaes 8～12.
Said medicine can be made any dosage form on the pharmaceutics, as tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a capsule.
The concrete preparation method of medicine of the present invention being made capsule is:
Said medicine is cleaned mix homogeneously by described parts by weight, be ground into 100～120 medicated powder, in incapsulating, sterilization is made capsule.
One of hypertensive main pathogenic factor is because human body periphery arteriolospasm strengthens human body periphery small artery resistance, thereby causes blood pressure to increase, and forms hypertension.The Therapeutic Principle should be suppressing the hyperactive liver and subsiding YANG, the spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., collateral dredging.The Hirudo removing blood stasis, stimulate the menstrual flow; Scolopendra relieve dizziness, high fever, infantile convulsions, epilepsy, etc. spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain; Pheretima clearing away heat and relieving the wind syndrome, collateral dredging, diuresis; Radix Astragali benefiting QI for strengthening the superficies, arresting sweating take off admittedly, inducing diuresis to remove edema; Rhizoma Gastrodiae relieving spasm by subduing liver-wind, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral.All medicines share, and can play suppressing the hyperactive liver and subsiding YANG, the effect of the spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., collateral dredging, alleviation periphery arteriolospasm, are used for the purpose that hypertensive treatment can be played good effect, have no side effect.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 45 routine hyperpietics that the curative effect of medicine of the present invention has been carried out clinical observation.
45 routine cases are divided into two groups at random, and 25 examples are organized in treatment, matched group 20 examples.All case is diagnosed as hypertension all according to the diagnostic criteria of " new Chinese medicine clinical guidance principle (first volume) ".
Diagnostic criteria
Systolic pressure is equal to or higher than 160mmHg(21.3kPa), diastolic pressure is equal to or higher than 95mmHg(12.721.3kPa), both have 1 through examining, and can make a definite diagnosis
Therapeutic Method
Matched group adopts FUFANG JIANGYA PIAN, and is oral, one time 2,3 times on the one; The treatment group adopts capsule medicine of the present invention to treat every day 3 times, each 3.20 days is a course of treatment.
Criterion of therapeutical effect
According to the criterion of therapeutical effect in " new Chinese medicine clinical guidance principle (first volume) ", produce effects: 1. diastolic pressure decline 10mmHg(1.3kPa) more than, and reach normal range; Though 2. diastolic pressure is not near normal, with 20 mmHg(2.7kPa that descend) or more than, must possess wherein 1; Effectively: 1. diastolic pressure descends not as good as 10mmHg(1.3kPa), but to reach normal range; 2. decline 10～19 mmHg(1.3 before diastolic pressure is treated～2.5kPa), but do not reach normal range; 3. 30 mmHg(4kPa descend before systolic pressure is treated); Must possess wherein 1; Invalid: as not reach above standard.
Two groups of case treatment back curative effect comparative results see Table 1.
Table 1 liang group case treatment back curative effect relatively
| Group | The example number | Produce effects n(%) | Effective n(%) | Invalid n(%) | Total effective rate n(%) |
| Matched group | 20 | 8（40） | 8（40） | 4（20） | 16（80） |
| The treatment group | 25 | 14（56） | 9（36） | 2（8） | 23（92） |
Statistical result showed, treatment group curative effect obviously is better than matched group, and two group differences are remarkable,
P＜0.05.
The specific embodiment
Embodiment 1
Get Hirudo 60g, Scolopendra 120g, Pheretima 240g, Radix Astragali 120g, Rhizoma Gastrodiae 120g mix homogeneously selected, that clear water is cleaned, be ground into 100～120 medicated powder, in incapsulating, sterilization is made capsule.
Embodiment 2
Get Hirudo 40g, Scolopendra 80g, Pheretima 160g, Radix Astragali 80g, Rhizoma Gastrodiae 80g mix homogeneously selected, that clear water is cleaned, be ground into 100～120 medicated powder, in incapsulating, sterilization is made capsule.
Claims (2)
1. hypertensive medicine of treatment is that crude drug prepares by the Chinese medicine of following portions by weight:
Hirudo 4～6 Scolopendras 8～12 Pheretimas 16～24
The Radix Astragali 8～12 Rhizoma Gastrodiaes 8～12.
2. the hypertensive medicine of treatment according to claim 1 is characterized in that described medicine is made capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110263863A CN102258702B (en) | 2011-09-07 | 2011-09-07 | Medicine for treating hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110263863A CN102258702B (en) | 2011-09-07 | 2011-09-07 | Medicine for treating hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102258702A true CN102258702A (en) | 2011-11-30 |
| CN102258702B CN102258702B (en) | 2012-08-29 |
Family
ID=45005668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110263863A Expired - Fee Related CN102258702B (en) | 2011-09-07 | 2011-09-07 | Medicine for treating hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102258702B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103463176A (en) * | 2013-09-23 | 2013-12-25 | 李小杵 | Medicament for treating hypertention |
| CN104971235A (en) * | 2015-07-11 | 2015-10-14 | 孙太辉 | Medicine for treating primary hypertension and preparation method thereof |
| CN108904713A (en) * | 2018-10-08 | 2018-11-30 | 云南中医学院 | A kind of Chinese medicine for treating cardiovascular disease |
| CN108904714A (en) * | 2018-10-08 | 2018-11-30 | 云南中医学院 | A kind of preparation method of Chinese medicine that treating cardiovascular disease |
| CN109939186A (en) * | 2019-03-26 | 2019-06-28 | 海南长永恒生物科技有限公司 | A kind of preparation method of Chinese materia medica preparation and its Chinese patent drug for treating hypertension |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028450A (en) * | 2007-02-07 | 2007-09-05 | 徐立君 | Medicinal composition for treating cardica cerebrovascular diseases |
| CN101524483A (en) * | 2009-03-06 | 2009-09-09 | 段世荣 | Capsule for treating hyperpiesis and apoplexy and preparation method thereof |
-
2011
- 2011-09-07 CN CN201110263863A patent/CN102258702B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028450A (en) * | 2007-02-07 | 2007-09-05 | 徐立君 | Medicinal composition for treating cardica cerebrovascular diseases |
| CN101524483A (en) * | 2009-03-06 | 2009-09-09 | 段世荣 | Capsule for treating hyperpiesis and apoplexy and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 《内蒙古民族大学学报(自然科学版) 》 20030615 史连和 中医药治疗高血压病进展 277-282 1-2 , 第3期 * |
| 《北京中医药》 20080831 程慧珍 中药在高血压治疗中的应用 646-648 1-2 第27卷, 第8期 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103463176A (en) * | 2013-09-23 | 2013-12-25 | 李小杵 | Medicament for treating hypertention |
| CN104971235A (en) * | 2015-07-11 | 2015-10-14 | 孙太辉 | Medicine for treating primary hypertension and preparation method thereof |
| CN108904713A (en) * | 2018-10-08 | 2018-11-30 | 云南中医学院 | A kind of Chinese medicine for treating cardiovascular disease |
| CN108904714A (en) * | 2018-10-08 | 2018-11-30 | 云南中医学院 | A kind of preparation method of Chinese medicine that treating cardiovascular disease |
| CN108904714B (en) * | 2018-10-08 | 2021-07-16 | 云南中医学院 | Preparation method of traditional Chinese medicine for treating cardiovascular diseases |
| CN108904713B (en) * | 2018-10-08 | 2021-07-16 | 云南中医学院 | Chinese medicine for treating cardiovascular disease |
| CN109939186A (en) * | 2019-03-26 | 2019-06-28 | 海南长永恒生物科技有限公司 | A kind of preparation method of Chinese materia medica preparation and its Chinese patent drug for treating hypertension |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102258702B (en) | 2012-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102258702B (en) | Medicine for treating hypertension | |
| CN103446426A (en) | Chinese medicine tea capable of lowering blood pressure and reducing blood fat | |
| CN102614305A (en) | Medicament for treating allergic purpura | |
| CN101822789B (en) | Hypotensor treating essential hypertension | |
| CN102614390A (en) | Medicine for treating hypertension | |
| CN1907357A (en) | Compound recipe pollen extract oral liquid for regulating blood pressure and blood fat, and process for preparing same | |
| CN100358568C (en) | Medicine for treating high blood pressure and its preparation method | |
| CN106265988A (en) | A kind of thin medicine moxibustion bar and preparation method thereof | |
| CN103550698B (en) | Traditional Chinese medicine composition for treating acute cholecystitis | |
| CN101199830B (en) | Heat-transfer dose medicament for treating migraine | |
| CN102552724B (en) | Chinese medicine composite for curing hypertension | |
| CN103316067A (en) | Medicine for treating headache and preparation method thereof | |
| CN103272118A (en) | Chinese herba preparation for treating hypertension and preparation method of Chinese herba preparation | |
| CN103463176A (en) | Medicament for treating hypertention | |
| CN101284045B (en) | Highly effective skin lotion and preparation method thereof | |
| CN104645177A (en) | Traditional Chinese medicine composition for treating flat wart | |
| CN103446337A (en) | Chinese medicine tea capable of lowering blood pressure | |
| CN104257774B (en) | A kind of Chinese medicine preparation of blood pressure lowering | |
| CN102949599B (en) | Traditional Chinese medicine preparation for reducing blood pressure | |
| CN108236674A (en) | The preparation method of rheumatoid rehabilitation paste | |
| CN102764275A (en) | Externally-applied traditional Chinese medicine for treating tumour and preparation method thereof | |
| CN102526685A (en) | Medicament for treating cervical spondylosis | |
| CN102319331B (en) | Medicine for removing necrotic tissue and promoting granulation | |
| KR20170120375A (en) | Chinese medicine preparation | |
| CN101284078A (en) | Nicandra physalodes (simple recipe) decocted in water for curing cardiovascular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120829 Termination date: 20130907 |